X-Linked Intellectual Disability-Hypotonia-Movement Disorder Syndrome: A Patient Guide
At a Glance
X-linked intellectual disability-hypotonia-movement disorder syndrome is an umbrella term for several genetic conditions. Identifying the specific gene helps clinicians tailor monitoring, therapies, and support to a child’s needs.
Important Note: This guide covers a broad clinical phenotype. Symptoms alone cannot identify the causal gene or predict inheritance. X-linked intellectual disability-hypotonia-movement disorder is an “umbrella” term for several distinct genetic conditions, each with its own specific monitoring and care needs.
X-linked intellectual disability-hypotonia-movement disorder syndrome is a clinical descriptive term for a complex neurodevelopmental condition characterized by three core challenges. This “triad” of symptoms includes intellectual disability, which affects how a child learns and solves problems; hypotonia, a state of low muscle tone that often presents as “floppiness” in infancy; and movement disorders, which involve involuntary or uncoordinated physical actions like twisting, shaking, or stiffness [1]. Because these symptoms involve the brain’s communication with the rest of the body, they impact many aspects of a child’s development, from their first motor milestones to how they eventually interact with the world around them [2].
The condition is rooted in the biology of the X chromosome. Because it is X-linked, the syndrome often affects males, who have only one X chromosome and therefore may lack a compensating copy for the affected gene, though females can also be affected depending on the exact condition [3]. While some families may have a history of these traits, many cases arise de novo, meaning the genetic change occurred for the first time in the child [4]. It is important for parents to understand that these changes are natural biological events; they are not caused by any lifestyle choices or actions taken during pregnancy [5].
While the syndrome’s name describes what is happening clinically, it actually serves as an “umbrella” for several distinct genetic conditions. Identifying the specific gene involved—such as SLC16A2, WDR45, or IQSEC2—is a critical step in a child’s care journey [6]. A precise genetic diagnosis moves the conversation from general descriptions to a focused management plan, as different genes can lead to unique health needs, such as specific thyroid monitoring or different patterns of movement over time [2][7].
Living with this condition requires a proactive, multidisciplinary approach to care. This model brings together a team of specialists, including neurologists, geneticists, and therapists, who work in harmony to support the child’s unique path [8]. While the journey involves navigating lifelong challenges, the focus of modern medicine is on maximizing a child’s comfort, improving their ability to communicate, and ensuring they can participate fully in their family and community life [9]. Through early intervention and dedicated support, the goal is to empower each child to reach their individual potential.
In this guide
6 chapters
Understanding the Diagnosis: X-Linked Intellectual Disability-Hypotonia-Movement Disorder
Learn what X-linked intellectual disability-hypotonia-movement disorder means, including symptoms, inheritance, genetic testing, supportive care, and next steps.
Symptoms and Developmental Expectations
Learn about X-linked intellectual disability-hypotonia-movement disorder syndrome, including low muscle tone, developmental delay, seizures, and feeding concerns.
Genetics, Biology, and Finding the Exact Diagnosis
Learn how X-linked intellectual disability-hypotonia-movement disorder syndrome is diagnosed, including gene testing, trio sequencing, inheritance, and VUS results.
Standard of Care and Symptom Management
Learn how X-linked intellectual disability-hypotonia-movement disorder is managed with therapy, movement treatments, communication support, and safer feeding.
Building Your Care Team and First Visit Prep
Learn how to build a care team for X-linked intellectual disability-hypotonia-movement disorder syndrome and prepare records, videos, and questions for visits.
Long-Term Outlook, Monitoring, and Support
Learn long-term care for X-linked intellectual disability-hypotonia-movement disorder syndrome, including bone health, breathing, feeding safety, and red flags.
Common questions in this guide
What is X-linked intellectual disability-hypotonia-movement disorder syndrome?
Why might my child need genetic testing for this syndrome?
Does an X-linked diagnosis always come from a parent?
What symptoms can this syndrome cause in a child?
Which specialists should care for a child with this syndrome?
What treatments and support can help my child?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on X-linked intellectual disability-hypotonia-movement disorder syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which of the specific genetic conditions under this umbrella does my child's testing suggest?
- 2.How will our care team coordinate between the neurologist, geneticist, and therapists to manage these three different types of symptoms?
- 3.What are our primary goals for my child's physical and communication development over the next six months?
- 4.Are there specific specialists, such as a pediatric movement disorder neurologist, whom we should add to our core team?
References
References (9)
- 1
Biallelic MED27 variants lead to variable ponto-cerebello-lental degeneration with movement disorders.
Maroofian R, Kaiyrzhanov R, Cali E, et al.
Brain : a journal of neurology 2023; (146(12)):5031-5043 doi:10.1093/brain/awad257.
PMID: 37517035 - 2
Expanding the phenotypic spectrum of Allan-Herndon-Dudley syndrome in patients with SLC16A2 mutations.
Remerand G, Boespflug-Tanguy O, Tonduti D, et al.
Developmental medicine and child neurology 2019; (61(12)):1439-1447 doi:10.1111/dmcn.14332.
PMID: 31410843 - 3
Two novel DNA variants associated with glucose-6-phosphate dehydrogenase deficiency found in Argentine pediatric patients.
Chaves A, Eberle SE, Defelipe L, et al.
Clinical biochemistry 2016; (49(10-11)):808-10.
PMID: 26827633 - 4
NEXMIF encephalopathy: an X-linked disorder with male and female phenotypic patterns.
Stamberger H, Hammer TB, Gardella E, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(2)):363-373 doi:10.1038/s41436-020-00988-9.
PMID: 33144681 - 5
Use of targeted next-generation sequencing for molecular diagnosis of craniosynostosis: Identification of a novel de novo mutation of EFNB1.
Yamamoto T, Igarashi N, Shimojima K, et al.
Congenital anomalies 2016; (56(2)):91-3 doi:10.1111/cga.12123.
PMID: 26208246 - 6
Genetic and metabolic investigations for neurodevelopmental disorders: position statement of the Canadian College of Medical Geneticists (CCMG).
Carter MT, Srour M, Au PB, et al.
Journal of medical genetics 2023; (60(6)):523-532 doi:10.1136/jmg-2022-108962.
PMID: 36822643 - 7
Quantitative retrospective natural history modeling of WDR45-related developmental and epileptic encephalopathy - a systematic cross-sectional analysis of 160 published cases.
Saffari A, Schröter J, Garbade SF, et al.
Autophagy 2022; (18(7)):1715-1727 doi:10.1080/15548627.2021.1990671.
PMID: 34818117 - 8
Clinical and Biochemical Monitoring of Monocarboxylate Transporter 8 Deficiency (Allan-Herndon-Dudley Syndrome) across the Lifespan: Practical Considerations for Multidisciplinary Care.
Dietrich JW, Jelesch E, Linder-Lucht M, et al.
Hormone research in paediatrics 2026; 1-14 doi:10.1159/000551857.
PMID: 41926547 - 9
Patients with Allan-Herndon-Dudley Syndrome (MCT8 Deficiency) Display Symptoms of Parkinsonism in Childhood and Respond to Levodopa/Carbidopa Treatment.
Wilpert NM, Hewitt AL, Pons R, et al.
Movement disorders : official journal of the Movement Disorder Society 2025; (40(5)):938-949 doi:10.1002/mds.30152.
PMID: 40088079
This guide explains the umbrella term X-linked intellectual disability-hypotonia-movement disorder for informational purposes only and does not constitute medical advice. A clinical geneticist and your child’s care team should interpret testing and plan individualized monitoring.